TE
SMMT icon

Tema ETFs’s Summit Therapeutics SMMT Stock Holding History

Tema ETFs’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76M Buy
121,097
+1,566
+1% +$27.8K 0.06% 199
2026
Q1 		$2.27M Buy
119,531
+23,749
+25% +$384K 0.15% 134
2025
Q4 		$1.68M Buy
95,782
+15,498
+19% +$292K 0.13% 171
2025
Q3 		$1.66M Sell
80,284
-26,659
-25% -$646K 0.14% 187
2025
Q2 		$2.28M Buy
106,943
+8,832
+9% +$201K 0.6% 60
2025
Q1 		$1.89M Buy
98,111
+71,470
+268% +$1.43M 0.57% 61
2024
Q4 		$475K Buy
+26,641
New +$516K 0.2% 101

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Tema ETFs's SMMT Position: Q2 2026 in Review

Tema ETFs increased its Summit Therapeutics (SMMT) stake by 1.3% in Q2 2026, buying an estimated $27.8K and bringing the position to 121,097 shares worth $1.76M. The position accounts for 0.06% of the portfolio, ranked #199.

Tema ETFs first reported a position in SMMT in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.28M in Q2 2025. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Tema ETFs held 121,097 shares of Summit Therapeutics worth $1.76M as of Q2 2026.
  • Tema ETFs bought 1,566 Summit Therapeutics shares in Q2 2026, an estimated $27.8K.
  • Summit Therapeutics made up 0.06% of Tema ETFs's portfolio in Q2 2026, its #199 holding.
  • Tema ETFs first reported a position in Summit Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Tema ETFs's Summit Therapeutics position peaked at $2.28M in Q2 2025.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.